Intensity Therapeutics In...

AI Score

0

Unlock

2.79
0.19 (7.31%)
At close: Jan 15, 2025, 3:58 PM
2.77
-0.84%
After-hours Jan 15, 2025, 03:59 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 147.00K 179.04K n/a n/a n/a
Gross Profit -147.00K -179.04K n/a n/a n/a
Operating Income -8.32M -7.63M -8.01M -6.22M -5.68M
Interest Income 324.00K 2.48K 2.61K 74.01K 150.71K
Pretax Income -10.54M -7.58M -7.90M -6.03M -5.38M
Net Income -10.54M -7.45M -7.89M -5.96M -5.23M
Selling & General & Admin 3.39M 2.42M 2.16M 1.17M 1.24M
Research & Development 4.79M 5.13M 5.86M 5.05M 4.44M
Other Expenses n/a 47.65K 115.51K 118.76K 144.99K
Operating Expenses 8.17M 7.55M 8.01M 6.22M 5.68M
Interest Expense 305.00K 81.78K 16.77K n/a n/a
Selling & Marketing Expenses -147.00K n/a n/a n/a n/a
Cost & Expenses 8.32M 7.55M 8.01M 6.22M 5.68M
Income Tax n/a -131.91K -2.61K -74.01K -150.71K
Shares Outstanding (Basic) 8.62M 13.10M 13.10M 13.10M 13.10M
Shares Outstanding (Diluted) 8.62M 13.10M 13.10M 13.10M 13.10M
EPS (Basic) -1.38 -0.57 -0.6 -0.45 -0.4
EPS (Diluted) -1.38 -0.57 -0.6 -0.45 -0.4
EBITDA -10.09M -7.40M -7.88M -6.03M -5.38M
Depreciation & Amortization 147.00K 179.04K 236.56K 206.30K 171.86K